Stenabolic

Category: pharmacological

Aliases: SR-9009

Pharmacological Mechanism

REV-ERB-α agonist — circadian-rhythm transcription factor activator that increases mitochondrial biogenesis + glucose oxidation in muscle. Marketed in research-chem space as "exercise mimetic"; oral bioavailability poor (<1% in rodents). Banned by WADA.

Half-Life (t½)

PO: 4h

Dosing Guidelines

• PO: Typical 20mg (Range: 10 - 30 mg)

Target Organ Systems

• endocrine
• musculoskeletal